Hiroeki Sahara Selected Research

Keratins (Keratin)

7/2011

Mammary adenoma with sebaceous differentiation in a dog.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroeki Sahara Research Topics

Disease

20	Neoplasms (Cancer) 01/2021 - 01/2002
4	Synovial Sarcoma (Synovioma) 01/2005 - 08/2002
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 08/2008
2	Ischemia 01/2015 - 07/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2009 - 08/2002
2	Necrosis 05/2008 - 01/2007
1	Carcinoma (Carcinomatosis) 03/2019
1	Hypoxia (Hypoxemia) 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Peripheral Arterial Disease 01/2015
1	Intermittent Claudication 01/2015
1	Infections 08/2012
1	Distemper (Canine Distemper) 08/2012
1	Infectious Canine Hepatitis (Canine Hepatitis, Infectious) 08/2012
1	Body Weight (Weight, Body) 08/2008
1	Reperfusion Injury 07/2007
1	Hemorrhage 01/2007
1	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2003
1	Osteosarcoma (Osteogenic Sarcoma) 01/2003
1	Genetic Translocation (Chromosomal Translocation) 12/2002
1	Squamous Cell Carcinoma of Head and Neck 08/2002
1	Ocular Paraneoplastic Syndromes 07/2002
1	Autoimmune Diseases (Autoimmune Disease) 07/2002
1	Signet Ring Cell Carcinoma 05/2002
1	Adenocarcinoma of Lung 01/2002

Drug/Important Bio-Agent (IBA)

7	Peptides (Polypeptides)IBA 01/2005 - 05/2002
4	AntigensIBA 04/2009 - 05/2002
3	HLA-A Antigens (HLA-A)IBA 01/2005 - 05/2002
3	HLA-A24 AntigenIBA 07/2004 - 07/2002
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 08/2008
2	Pharmaceutical PreparationsIBA 01/2015 - 01/2007
2	1- mono- O- acyl- 3- O- (alpha- D- sulfoquinovosyl)- glycerideIBA 08/2012 - 05/2008
2	VaccinesIBA 08/2012 - 04/2009
2	Cancer VaccinesIBA 04/2009 - 05/2002
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 08/2008 - 01/2007
2	GlycolipidsIBA 08/2008 - 01/2007
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Radiation-Sensitizing AgentsIBA 01/2021
1	pyrenocine AIBA 12/2019
1	sulfoquinovosylacylpropanediolIBA 03/2019
1	RNA Helicases (RNA Helicase)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Cilostazol (Pletal)FDA LinkGeneric 01/2015
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2015
1	Small Interfering RNA (siRNA)IBA 08/2012
1	Thrombospondin 1IBA 08/2012
1	Phenobarbital (Luminal)FDA Link 07/2011
1	Keratins (Keratin)IBA 07/2011
1	Complementary DNA (cDNA)IBA 05/2009
1	Interleukin-16 (Interleukin 16)IBA 05/2009
1	Interleukin-10 (Interleukin 10)IBA 05/2009
1	Biological ProductsIBA 04/2009
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2008
1	Cyclin EIBA 08/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2008
1	sulfonoglycolipidIBA 07/2007
1	sulfoquinovosylacylglycerolIBA 07/2007
1	Liposomes (Liposome)IBA 07/2007
1	dehydroaltenusinIBA 01/2007
1	DNA Polymerase I (Klenow Fragment)IBA 01/2007
1	Angiogenesis InhibitorsIBA 02/2006
1	HLA-DRB1 Chains (HLA DRB1)IBA 08/2002
1	RecoverinIBA 07/2002
1	AcidsIBA 05/2002
1	HLA-A31 antigenIBA 05/2002
1	peptide F4.2IBA 05/2002
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2002
1	sulfolipidsIBA 01/2002

Therapy/Procedure

5	Immunotherapy 04/2009 - 05/2002
1	Radiotherapy 01/2021
1	Therapeutics 09/2020
1	Intravenous Injections 03/2019
1	Intravenous Administration 03/2019
1	Subcutaneous Injections 08/2008
1	Oral Administration 08/2008